Dr. Ligon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
450 Brookline Ave
JF215
Boston, MA 02215Phone+1 617-732-5500- Is this information wrong?
Summary
- Dr. Keith Ligon is Pathologist and Chief of Neuropathology at the MGB-Brigham and Women's Hospital and Dana-Farber Cancer Institute in Boston, MA. He is affiliated with multiple hospitals in the area, including Mass General Brigham's Brigham and Women's Hospital, Dana-Farber Cancer Institute, and Boston Children's Hospital. He received his medical degree from MD Anderson Cancer Center and McGovern Medical School at UTHealth and has been in practice 20 years. He specializes in neuropathology, anatomic pathology, pediatric pathology, and molecular diagnostics. He is experienced in oncologic pathology. He has more than 200 publications and over 500 citings.
Education & Training
Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 1997 - 2001
McGovern Medical School at UTHealthClass of 1997- Brigham and Women's HospitalFellowship, Neuropathology
Certifications & Licensure
MA State Medical License 2001 - 2025- American Board of Pathology Anatomic Pathology
- American Board of Pathology Neuropathology
Clinical Trials
- Imatinib Mesylate in Treating Patients With Recurrent Meningioma Start of enrollment: 2003 Feb 01
- Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma Start of enrollment: 2005 Apr 01
- Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors Start of enrollment: 2007 May 25
- Join now to see all
Publications & Presentations
PubMed
- Noninvasive Molecular Subtyping of Pediatric Low-Grade Glioma with Self-Supervised Transfer Learning.Ligon, K. L., Divyanshu Tak, Zezhong Ye, Anna Zapaischykova, Yining Zha, Aidan Boyd, Sridhar Vajapeyam, Rishi Chopra, Hasaan Hayat, Sanjay P Prabhu, Kevin X Liu, Hesha...> ;Radiology. Artificial Intelligence. 2024 May 1
- 3 citationsMutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendroglioma.Avishay Spitzer, Simon Gritsch, Masashi Nomura, Alexander Jucht, Jerome Fortin, Ramya Raviram, Hannah R Weisman, L Nicolas Gonzalez Castro, Nicholas Druck, Rony Chanoc...> ;Cancer Cell. 2024 Apr 2
- Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed Glioblastoma.Ligon, K. L., Mary Jane Lim-Fat, J Bryan Iorgulescu, Rifaquat Rahman, Varun Bhave, Alona Muzikansky, Eleanor Woodward, Sydney Whorral, Marie Allen, Mehdi Touat, Xiaome...> ;Clinical Cancer Research. 2024 Apr 1
- Join now to see all
Journal Articles
- Immunophenotyping of Pediatric Brain Tumors: Correlating Immune Infiltrate with Histology, Mutational Load, and Survival and Assessing Clonal T Cell ResponseIsaac H Solomon, Mark W Kieran, Gabriel K Griffin, Pratiti Bandopadhayay, Jerome Ritz, Ashley S Plant, Keith L Ligon, Glenn Dranoff, Journal of Neuro-Oncology
Press Mentions
Weighing Cancer Cells Helps Predict Treatment OutcomesOctober 14th, 2021- Cancer Drug Response and Outcome Predicted from Cell Mass ChangesOctober 7th, 2021
- New Study Finds Link Between Patient Survival and Changes in Tumor Cell Mass in Brain CancerOctober 6th, 2021
- Join now to see all
Grant Support
- Shared Resources CoreNational Cancer Institute2011–2012
- OLIG Function In CNS Development And TumorigenesisNational Institute Of Neurological Disorders And Stroke2006–2008
- OLIG Function In CNS Development And TumorigenesisNational Institute Of Neurological Disorders And Stroke2004–2005
Hospital Affiliations
Brigham and Women's HospitalBoston, Massachusetts
Boston Children's HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
